β-phenylethylamine, a small molecule with a large impact
- PMID: 24482732
- PMCID: PMC3904499
β-phenylethylamine, a small molecule with a large impact
Abstract
During a screen of bacterial nutrients as inhibitors of Escherichia coli O157:H7 biofilm, the Prüß research team made an intriguing observation: among 95 carbon and 95 nitrogen sources tested, β-phenylethylamine (PEA) performed best at reducing bacterial cell counts and biofilm amounts, when supplemented to liquid beef broth medium. This review article summarizes what is known about PEA. After some starting information on the chemistry of the molecule, we focus on PEA as a neurotransmitter and then move on to its role in food processing. PEA is a trace amine whose molecular mechanism of action differs from biogenic amines, such as serotonin or dopamine. Especially low or high concentrations of PEA may be associated with specific psychological disorders. For those disorders that are characterized by low PEA levels (e.g. attention deficit hyperactivity disorder), PEA has been suggested as a 'safe' alternative to drugs, such as amphetamine or methylphenidate, which are accompanied by many undesirable side effects. On the food processing end, PEA can be detected in food either as a result of microbial metabolism or thermal processing. PEA's presence in food can be used as an indicator of bacterial contamination.
Keywords: antimicrobial; neurotransmitter.
Figures
, dopamine
, serotonin receptor
, dopamine receptor
PEA
, amphetamine
, methylphenidate 
References
-
- American Psychiatric Association . Diagnostic and statistical manual of mental disorder. 4h ed Washington DC: 2000.
-
- Artigas F. Developments in the field of antidepressants, where do we go now? Eur Neuropsychopharmacol. 2013 doi: 10.1016/j.euroneuro.2013.04.013. Epub ahead of print. - PubMed
-
- Bailey BA, Philips SR, Boulton AA. In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine. Neurochem Res. 1987;12:173–178. - PubMed
-
- Baker GB, Bornstein RA, Rouget AC, Ashton SE, Van Muyden JC, Coutts RT. Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry. 1991;29:15–22. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources